At CROI 2026, experts warned that missing HBV screening risks reactivation during HIV therapy switches.

Hepatitis B vaccination at birth is safe and effective compared with a delayed first dose, according to new research.

The review confirms the universal hepatitis B birth dose has reduced pediatric incidence by 99% since its 1991 implementation. A comprehensive review published in Pediatrics found no evidence to ...

Among patients with HIV, standardized protocols are necessary to ensure hepatitis B virus (HBV) screening occurs before initiating antiretroviral therapy regimens that lack anti-HBV activity, ...

Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes. The test uses the DASH rapid PCR system, originally developed for COVID, ...

This prospective, real-world cohort study evaluated HBV serologic profiles and the risk of HBV reactivation or incident HBV infection after switching to long-acting ...